Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000063

Director sold 7,791 shares at $27.55 ($214,642)

  • Director acquired 15,934 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

FOUSE JACQUALYN A · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-08 Exercise or conversion : show line 1 in the form 10b5-1 +15,934 145,187 D
2024-04-10 Sale : show line 2 in the form 10b5-1 −7,791 $27.55 $214,642 137,396 D
Open-market sales · 7,791 sh · avg $27.55 · $214,642

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-08 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −15,934 15,933 D
Loading xslF345X05/wk-form4_1712779426.xml…